FDA sets panel review dates for analgesic Acurox and infantile spasms therapy Acthar
17 March 2010
Nancy Faigen
Please Login to read the full article.
17 March 2010
Nancy Faigen
Nancy.faigen@informausa.com
The
US FDA's anaesthetic and life support drugs advisory committee, in conjunction with the drug safety and risk management advisory committee, has scheduled a meeting for 22 April to review
Acura Pharmaceuticals' investigational abuse-deterring analgesic, Acurox (oxycodone plus niacin). Acura's...
Please Login to read the full article.
RELATED CONTENT
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
